Nisa Investment Advisors
ACTU

Nisa Investment Advisors’s Actuate Therapeutics ACTU Stock Holding History

Nisa Investment Advisors’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238 Buy
+87
New +$360 ﹤0.01% 2973

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nisa Investment Advisors's ACTU Position: Q1 2026 in Review

Nisa Investment Advisors opened a new position in Actuate Therapeutics (ACTU) in Q1 2026: 87 shares worth $238. The stake represents ﹤0.01% of the portfolio and ranks #2973 among its holdings.

61 funds tracked by Wall St. Rank hold ACTU as of Q1 2026.

  • Nisa Investment Advisors held 87 shares of Actuate Therapeutics worth $238 as of Q1 2026.
  • Actuate Therapeutics was a new Nisa Investment Advisors position in Q1 2026.
  • Actuate Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2973 holding.
  • 61 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.